Adaptam Therapeutics raises €3M in pre-seed funding led by Criteria Bio Ventures to advance its cancer immunotherapy programs.
Amount Raised
€3 Million
Round Type
Pre-Seed
San SebastiánBiotechnologyHealth CareInvestors
Description
Adaptam Therapeutics, a San Sebastián-based biotech company, closed a €3M pre-seed financing round. The round was led by Criteria Bio Ventures, with two of its members joining the board. The funds will be used to develop cancer immunotherapies targeting immunosuppressive myeloid cells. Adaptam aims to enter the preclinical phase in multiple oncology indications.
Quick answer
Adaptam Therapeutics raised €3 Million in a Pre-Seed round, dated October 27, 2025. Investors: Criteria Bio Ventures. Adaptam Therapeutics is based in San Sebastián, Basque Country, Spain.
- How much did Adaptam Therapeutics raise?
- Adaptam Therapeutics raised €3 Million in a Pre-Seed round on October 27, 2025.
- Who invested in Adaptam Therapeutics?
- Criteria Bio Ventures is named as investors in this round.
- What does Adaptam Therapeutics do?
- Adaptam Therapeutics is a biotech company based in San Sebastián, Spain, focused on pioneering cancer immunotherapies that specifically target immunosuppressive myeloid cells.
- Where is Adaptam Therapeutics based and how big is it?
- Adaptam Therapeutics is based in San Sebastián, Basque Country, Spain. Fundz records about 3 employees.
- Who are the decision-makers at Adaptam Therapeutics?
- Fundz holds 2 contacts at Adaptam Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Adaptam Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Zegenex raised $215K (Pre-Seed) on December 11, 2025.
- Prolynx raised $70M (Series A) on December 11, 2025.
- Disco Pharmaceuticals raised $42M (Seed) on December 11, 2025.
- Allegria Therapeutics raised $5.1M (Seed) on December 11, 2025.
- Subsense raised $10M (Funding Round) on December 11, 2025.
- Cayuga Biotech raised $8M (Seed) on December 11, 2025.
Who to call at Adaptam Therapeutics, and when
A new round usually means Adaptam Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Adaptam Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Adaptam Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Adaptam Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adaptam Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Adaptam Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.